OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
Eli Hatchwell, Edward B. Smith, Shapour Jalilzadeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 14
Eli Hatchwell, Edward B. Smith, Shapour Jalilzadeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 14
Showing 14 citing articles:
Liquid Biopsy in Neurological Diseases
Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1911-1911
Open Access | Times Cited: 29
Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1911-1911
Open Access | Times Cited: 29
Progressive Multifocal Leukoencephalopathy
Finja Schweitzer, Sarah Laurent, Irene Cortese, et al.
Neurology (2023) Vol. 101, Iss. 16, pp. 700-713
Open Access | Times Cited: 23
Finja Schweitzer, Sarah Laurent, Irene Cortese, et al.
Neurology (2023) Vol. 101, Iss. 16, pp. 700-713
Open Access | Times Cited: 23
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis
Lorenzo Vittorio Rindi, Drieda Zaçe, Neva Braccialarghe, et al.
Drug Safety (2024) Vol. 47, Iss. 4, pp. 333-354
Closed Access | Times Cited: 10
Lorenzo Vittorio Rindi, Drieda Zaçe, Neva Braccialarghe, et al.
Drug Safety (2024) Vol. 47, Iss. 4, pp. 333-354
Closed Access | Times Cited: 10
An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy
Jacob Kaiserman, Bethany A. O’Hara, Sheila A. Haley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8580-8580
Open Access | Times Cited: 10
Jacob Kaiserman, Bethany A. O’Hara, Sheila A. Haley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8580-8580
Open Access | Times Cited: 10
Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy
Marie Deffner, Tilman Schneider-Hohendorf, Andreas Schulte‐Mecklenbeck, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101622-101622
Open Access | Times Cited: 3
Marie Deffner, Tilman Schneider-Hohendorf, Andreas Schulte‐Mecklenbeck, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101622-101622
Open Access | Times Cited: 3
Liquid Biopsy in Neurological Diseases
Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, et al.
(2023)
Open Access | Times Cited: 7
Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, et al.
(2023)
Open Access | Times Cited: 7
Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient
Panos Arvanitis, Dimitrios Farmakiotis, Ari Pelcovits
Current Oncology (2024) Vol. 31, Iss. 5, pp. 2670-2678
Open Access | Times Cited: 2
Panos Arvanitis, Dimitrios Farmakiotis, Ari Pelcovits
Current Oncology (2024) Vol. 31, Iss. 5, pp. 2670-2678
Open Access | Times Cited: 2
Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
Evgenia Emmanouilidou, Δέσποινα Κοσμαρά, Efrosini Papadaki, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6945-6945
Open Access | Times Cited: 6
Evgenia Emmanouilidou, Δέσποινα Κοσμαρά, Efrosini Papadaki, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6945-6945
Open Access | Times Cited: 6
Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
Joseph R. Berger, Hans‐Peter Hartung
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
Joseph R. Berger, Hans‐Peter Hartung
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification
Charalampos Skarlis, Vassilis Papadopoulos, Sylvia Raftopoulou, et al.
Journal of the Neurological Sciences (2024) Vol. 461, pp. 123046-123046
Closed Access | Times Cited: 1
Charalampos Skarlis, Vassilis Papadopoulos, Sylvia Raftopoulou, et al.
Journal of the Neurological Sciences (2024) Vol. 461, pp. 123046-123046
Closed Access | Times Cited: 1
Highly restrictive and directional penetration of the blood cerebral spinal fluid barrier by JCPyV
Bethany A. O’Hara, Avraham S. Lukacher, Kaitlin Garabian, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012335-e1012335
Open Access | Times Cited: 1
Bethany A. O’Hara, Avraham S. Lukacher, Kaitlin Garabian, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012335-e1012335
Open Access | Times Cited: 1
Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study
Dejan Jakimovski, Katelyn Kavak, Karen Zakalik, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122781-122781
Closed Access | Times Cited: 1
Dejan Jakimovski, Katelyn Kavak, Karen Zakalik, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122781-122781
Closed Access | Times Cited: 1
Multiple sclerosis
Xiaoming Jia, Jorge R. Oksenberg, Stephen L. Hauser, et al.
Elsevier eBooks (2024), pp. 385-415
Closed Access
Xiaoming Jia, Jorge R. Oksenberg, Stephen L. Hauser, et al.
Elsevier eBooks (2024), pp. 385-415
Closed Access
